Back to results
US 2008/0306086 A1Published application
Prolinamide derivatives as nk3 antagonists
AssigneeHoffmann-La Roche Inc.
InventorsBo Han, Henner Knust, Matthias Nettekoven, Hasane Ratni, Xihan Wu
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula I wherein R2 R3, R4, R5, X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof which are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
Claims16
A compound of formula I
- wherein
- R1 is hydrogen, halogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy, or lower alkoxy substituted by halogen;
- R2 is hydrogen or lower alkyl;
- R3 and R4 together with the N-atom to which they are attached form a non aromatic heterocyclic group, selected from
- R5 is hydrogen or halogen;
- R6 is phenyl, unsubstituted or substituted by cyano, halogen, lower alkyl, lower alkoxy, CF3, —(CH2)2O-lower alkyl, C(O)-lower alkyl or C(O)O-lower alkyl, or is pyridinyl, unsubstituted or substituted by CF3, or is —C(O)-phenyl;
- R7 is hydrogen or lower alkoxy;
- R8 is phenyl, lower alkyl or —C(O)O-lower alkyl;
- R9 is hydrogen or S(O)2-lower alkyl;
- R10 is hydrogen or cycloalkyl;
- X is —CH2— or —C(O)—;
- p is 1 or 2;
- n is 1, 2 or 3;
- and
- o is 1 or 2;
- or a pharmaceutically acceptable acid addition salt thereof.
13 more elements
A pharmaceutical composition comprising a therapeutically effective amount of a compound of formula I
- wherein
- R1 is hydrogen, halogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy, or lower alkoxy substituted by halogen;
- R2 is hydrogen or lower alkyl;
- R3 and R4 together with the N-atom to which they are attached form a non aromatic heterocyclic group, selected from
- R5 is hydrogen or halogen;
- R6 is phenyl, unsubstituted or substituted by cyano, halogen, lower alkyl, lower alkoxy, CF3, —(CH2)2O-lower alkyl, C(O)-lower alkyl or C(O)O-lower alkyl, or is pyridinyl, unsubstituted or substituted by CF3, or is —C(O)-phenyl;
- R7 is hydrogen or lower alkoxy;
- R8 is phenyl, lower alkyl or —C(O)O-lower alkyl;
- R9 is hydrogen or S(O)2-lower alkyl;
- R10 is hydrogen or cycloalkyl;
- X is —CH2— or —C(O)
- p is 1 or 2;
- n is 1, 2 or 3;
- and
- o is 1 or 2;
- or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable carrier.
13 more elements
Dependencies are inferred from the claim text.